| Aβ | amyloid β peptides |
| ACA | acetoacetate |
| ACh | acetylcholine |
| ACMSD | 2-amino-3-carboxymuconate-semialdehyde decarboxylase |
| AD | Alzheimer’s disease |
| AHR | aryl hydrocarbon receptor |
| ALCAR | acetyl-L-carnitine |
| α-7nAChR | α7 nicotinic acetylcholine receptor |
| ALS | amyotrophic lateral sclerosis |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid |
| AMPK | 5′ adenosine monophosphate-activated protein kinase |
| AMSDH | 2-aminomuconate-6-semialdehyde dehydrogenase |
| Apo A-I | apo-lipoprotein A-I |
| Apo B | apolipoprotein B |
| ATP | adenosine triphosphate |
| BBB | blood–brain barrier |
| BDNF | brain-derived neurotrophic factor |
| CHMP | Committee for Medicinal Products for Human Use |
| Chol | cholesterol |
| CNS | central nervous system |
| CoA | coenzyme A |
| CSF | cerebrospinal fluid |
| dβHB | d-β-hydroxybutyrate |
| DHLA | dihydrolipoic acid |
| DOPAC | 3,4-dihydroxyphenylacetic acid |
| EAE | experimental autoimmune encephalomyelitis |
| FDA | U.S. Food and Drug Administration |
| GPR35 | G protein-coupled receptor 35 |
| GSH | glutathione |
| 3HAO | 3-hydroxyanthranilate 3,4-dioxygenase |
| HD | Huntington’s disease |
| HDL | high-density lipoprotein |
| 3HK | 3-hydroxy-L-kynurenine |
| HMG-CoA | β-hydroxy-methylglutaryl-CoA |
| ICAM | soluble cell adhesion molecule |
| IDO | indoleamine 2,3-dioxygenase |
| IFN-γ | interferon-γ |
| IL-4 | interleukin-4 |
| i.p. injection | intraperitoneal injection |
| KAT | kynurenine aminotransferase |
| KB | ketone body |
| KGDHC | α-ketoglutarate dehydrogenase complex |
| KMO | kynurenine 3-monooxygenase |
| KP | kynurenine pathway |
| KYN | L-kynurenine |
| KYNA | kynurenic acid |
| LA | α-lipoic acid |
| LBF | Lactobacillus bulgaricus Factor |
| L-dopa | levodopa |
| LPS | lipopolysaccharide |
| MDD | major depressive disorder |
| MMP-9 | matrix metalloproteinase-9 |
| MPP+ | 1-methyl-4-phenylpyridinium ion |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| MS | multiple sclerosis |
| NAD+ | nicotinamide adenine dinucleotide |
| ND | neurodegenerative diseases |
| NMDARs | N-methyl-d-aspartic acid receptors |
| 3-NP | 3-nitropropionic acid |
| 6-OHDA | 6-hydroxydopamine |
| PD | Parkinson’s disease |
| PDH | pyruvate dehydrogenase |
| PIC | picolinic acid |
| PKAN | pantothenate kinase-associated neurodegeneration |
| QPRT | quinolinic acid phosphoribosyltransferase |
| QUIN | quinolinic acid |
| RONS | reactive oxygen and nitrogen species |
| ROS | reactive oxygen species |
| RR MS | relapsing-remitting MS |
| SDH | succinate dehydrogenase |
| -SH | sulfhydryl |
| SNpc | substantia nigra pars compacta |
| TCA | tricarboxylic acid cycle |
| TDO | tryptophan 2,3-dioxygenase |
| TG | triglyceride |
| TGF-β | tumor growth factor-β |
| TIMP1 | tissue inhibitor of metalloproteinases |
| TNF-α | tumor necrosis factor-α |
| TRP | tryptophan |